Anoro Ellipta inhalation powder

Anoro Ellipta is a prescription medication used for the long-term treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It combines two bronchodilators: umeclidinium bromide (55 micrograms) and vilanterol (22 micrograms), delivered via the Ellipta inhaler. Manufactured by GlaxoSmithKline (GSK), a British multinational pharmaceutical company headquartered in Brentford, England, Anoro Ellipta is produced in multiple countries to meet global demand. GSK is a leading developer of medicines and vaccines, with a strong focus on respiratory diseases. The company operates worldwide, with its ultimate ownership remaining with GlaxoSmithKline plc, headquartered in the United Kingdom. There are no known local subsidiaries responsible for the brand in Sweden.